Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Mercalis, formerly known as TrialCard, is a leading provider of commercialization services for the life sciences industry, specializing in patient support, hub services, and market access solutions. The company's flagship platform, GoalAssist, is a proprietary patient support and hub services technology designed to streamline the patient journey from prescription to therapy adherence. GoalAssist integrates clinical, financial, and administrative data to provide real-time visibility into patient status and program performance. Mercalis serves a broad range of pharmaceutical and biotech clients, helping them navigate complex reimbursement landscapes and improve patient outcomes through data-driven engagement. The company has expanded its capabilities through strategic acquisitions, including The CM Group and Policy Reporter, to offer a comprehensive suite of commercialization tools.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on GoalAssist.